𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Loss of heterozygosity at 17p13 in gastric cancer and colorectal cancer

✍ Scribed by Mingfa Li; Xiangnian Shan; Guojun Wu; Long Yu; Shouyuan Zhao


Publisher
Chinese Anti-Cancer Association
Year
1997
Tongue
English
Weight
336 KB
Volume
9
Category
Article
ISSN
1000-9604

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Loss of heterozygosity and K-rasgene mut
✍ G. N. Ranzani; B. Renault; N. S. Pellegata; P. Fattorini; E. Magni; F. Bacci; D. πŸ“‚ Article πŸ“… 1993 πŸ› Springer 🌐 English βš– 744 KB

In order to identify relevant genetic lesions in gastric carcinoma, we searched for tumor suppressor gene inactivation and K-ras gene mutations by analyzing tumor and control DNAs from 34 patients. These were from an epidemiologically defined area of Italy characterized by one of the world's highest

Frequent loss of heterozygosity at telom
✍ Ikuo Yana; Hiroki Kurahashi; Shoji Nakamori; Masao Kameyama; Tsutomu Nakamura; M πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 French βš– 552 KB

To date, several tumor-suppressor genes responsible for the tumorigenesis of colorectal cancer have been identified. However, studies of loss of heterozygosity (LOH) have suggested several chromosomal regions which may contain additional tumor-suppressor genes for colorectal cancer. To determine the

Microsatellite instability and/or loss o
✍ Yih-Horng Shiao; Daniela Bovo; Maria Guido; Carlo Capella; Mauro Cassaro; Grazie πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 44 KB πŸ‘ 2 views

Gastric cancers are rarely diagnosed before the age of 40 years and the incidence reaches a peak during the 7th decade in the general population. A molecular mechanism of early tumor onset may be determined by comparing microsatellite instability (MSI), indicative of error-prone mismatch repair, and

Loss of heterozygosity at chromosome 17p
✍ Evgeny N. Imyanitov; Oleg I. Chernitsa; Irina F. Nikiforova πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 French βš– 703 KB

## Abstract Sixty DNA samples from breast carcinoma (BC) patients were analyzed by Southern blot to examine certain oncogene and anti‐oncogene alterations. Amplification of the HER‐2 oncogene was detected in 15 tumours (25%), c‐myc in 2 (3%) only and HER‐1 in none. Distribution of Hras‐1 oncogene a